Curidium Medica plc Joins the Personalized Medicine Coalition

August 1, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

London, UK, 1 August 2007, Curidium Medica plc, (LSE:CUR.L - News), the personalized medicine company focused on bringing the right drug to the right patient, today announced that it has joined the US-based Personalized Medicine Coalition (PMC).

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe